Genepod - Moving therapeutics ahead in Genomics: response to imatinib in infantile myofibromatosis

from Springer Nature · host Springer Nature

Related article: A patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib https://www.nature.com/gim/journal/vaop/ncurrent/full/gim2017104a.html

Episode metadata supplied by the publisher feed · Published Oct 18, 2017

Embed this episode

Attribution link and audio player

NOW PLAYING

Genepod - Moving therapeutics ahead in Genomics: response to imatinib in infantile myofibromatosis

0:00 6:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Springer Nature?

This episode is 6 minutes long.

When was this Springer Nature episode published?

This episode was published on October 18, 2017.

Can I download this Springer Nature episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!